Abstract

MRI contrast is often enhanced using a contrast agent. Gd3+-complexes are the most widely used metallic MRI agents, and several types of Gd3+-based contrast agents (GBCAs) have been developed. Furthermore, recent advances in MRI technology have, in part, been driven by the development of new GBCAs. However, when designing new functional GBCAs in a small-molecular-weight or nanoparticle form for possible clinical applications, their functions are often compromised by poor pharmacokinetics and possible toxicity. Although great progress must be made in overcoming these limitations and many challenges remain, new functional GBCAs with either small-molecular-weight or nanoparticle forms offer an exciting opportunity for use in precision medicine.

Original languageEnglish
Pages (from-to)639-661
Number of pages23
JournalFuture Medicinal Chemistry
Volume10
Issue number6
DOIs
StatePublished - Mar 2018

Keywords

  • contrast agent
  • gadolinium
  • magnetic resonance imaging

Fingerprint

Dive into the research topics of 'Gadolinium as an MRI contrast agent'. Together they form a unique fingerprint.

Cite this